Bb Biotech as of Dec. 31, 2015
Portfolio Holdings for Bb Biotech
Bb Biotech holds 30 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 12.2 | $432M | 3.6M | 119.76 | |
| Incyte Corporation (INCY) | 11.5 | $407M | 3.8M | 108.45 | |
| Ionis Pharmaceuticals (IONS) | 11.4 | $404M | 6.5M | 61.93 | |
| Gilead Sciences (GILD) | 7.9 | $281M | 2.8M | 101.19 | |
| Radius Health | 7.4 | $263M | 4.3M | 61.54 | |
| Alexion Pharmaceuticals | 5.6 | $197M | 1.0M | 190.75 | |
| Neurocrine Biosciences (NBIX) | 5.0 | $177M | 3.1M | 56.57 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $172M | 1.4M | 125.83 | |
| Agios Pharmaceuticals (AGIO) | 4.0 | $140M | 2.2M | 64.92 | |
| Medivation | 3.5 | $125M | 2.6M | 48.34 | |
| Halozyme Therapeutics (HALO) | 3.4 | $122M | 7.0M | 17.33 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $111M | 205k | 542.87 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $107M | 1.1M | 94.14 | |
| Novavax | 2.0 | $70M | 8.3M | 8.39 | |
| Tesaro | 1.8 | $64M | 1.2M | 52.32 | |
| Cempra | 1.8 | $62M | 2.0M | 31.13 | |
| Juno Therapeutics | 1.6 | $57M | 1.3M | 43.97 | |
| Alder Biopharmaceuticals | 1.4 | $50M | 1.5M | 33.03 | |
| Kite Pharma | 1.3 | $46M | 750k | 61.62 | |
| Ptc Therapeutics I (PTCT) | 1.2 | $42M | 1.3M | 32.40 | |
| Sage Therapeutics (SAGE) | 1.2 | $41M | 709k | 58.30 | |
| Intercept Pharmaceuticals In | 1.1 | $38M | 256k | 149.35 | |
| Puma Biotechnology (PBYI) | 0.9 | $34M | 432k | 78.40 | |
| Prothena (PRTA) | 0.6 | $22M | 320k | 68.11 | |
| Infinity Pharmaceuticals (INFIQ) | 0.6 | $21M | 2.7M | 7.85 | |
| Esperion Therapeutics (ESPR) | 0.6 | $20M | 909k | 22.26 | |
| Clovis Oncology | 0.5 | $19M | 528k | 35.00 | |
| Achillion Pharmaceuticals | 0.4 | $14M | 1.3M | 10.79 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $8.0M | 467k | 17.16 | |
| Tetraphase Pharmaceuticals | 0.1 | $3.7M | 366k | 10.03 |
